Disease Mutation Targeted | GenomeWeb

Using the CRISPR-Cas9 system, Massachusetts Institute of Technology researchers were able to correct a mutation in a mouse model of the human disease hereditary tyrosinemia, a fatal genetic disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.